New Monoclonal Antibodies Adding Power to CLL Treatment

The monoclonal antibody, Rituximab, has been a backbone of CLL treatment for several years. It targets a protein on the CLL cells. Now a more powerful antibody may be available soon and has shown prom... Author: patientpower Added: 09/17/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts